Association of Behavioral Nudges With High-Value Evidence-Based Prescribing in Oncology

JAMA Oncol. 2020 Jul 1;6(7):1104-1106. doi: 10.1001/jamaoncol.2020.0746.

Abstract

This interrupted time series analysis evaluates the association of nudges with zoledronate prescription vs more expensive denosumab.

MeSH terms

  • Aged
  • Bone Density Conservation Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Choice Behavior
  • Denosumab / therapeutic use*
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Medical Oncology
  • Middle Aged
  • Oncologists / psychology*
  • Practice Patterns, Physicians'*
  • Prostatic Neoplasms / drug therapy*
  • Zoledronic Acid / therapeutic use*

Substances

  • Bone Density Conservation Agents
  • Denosumab
  • Zoledronic Acid